[{"Assets_0_Q3_USD":436388000.0,"CommonStockSharesConverted_0_Q3_shares":35839196.0,"CommonStockSharesOutstanding_0_Q3_shares":35839196.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-43685000.0,"NetIncomeLossConverted_1_Q3_USD":-20483000.0,"NetIncomeLossConverted_3_Q3_USD":-51172000.0,"StockholdersEquity_0_Q3_USD":420524000.0,"EarningsPerShareBasic_1_Q3_USD":-0.63,"EarningsPerShareBasic_3_Q3_USD":-2.54,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191104"}]